Cargando…
SUN-646 A Novel Population of FOXO1-Expressing Cells in the Stomach Controls Cell Plasticity by Regulating the Cyclin CCNE1
A promising new therapy for type 1 diabetes is the reprogramming of gut enteroendocrine cells into cells that produce insulin. The mechanism by which gut epithelial cells are converted into cells that make insulin remains unknown. We have previously found that elimination of Foxo1 in neurogenin3 (Ng...
Autores principales: | McKimpson, Wendy M, Kuo, Taiyi, Kitamoto, Takumi, Higuchi, Sei, Haeusler, Rebecca, Accili, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209326/ http://dx.doi.org/10.1210/jendso/bvaa046.528 |
Ejemplares similares
-
FOXO1 Is Present in Stomach Epithelium and Determines Gastric Cell Distribution
por: McKimpson, Wendy M., et al.
Publicado: (2022) -
SAT-646 Do Diabetes and Hypertension Mobile Apps Overlap?
por: Wong, Jonathan, et al.
Publicado: (2020) -
MON-646 Novel Use of GLP-1 Receptor Agonist Therapy in MODY-1 (HNF4A Mutation)
por: Broome, David Tyler, et al.
Publicado: (2020) -
Chemical induction of gut β-like-cells by combined FoxO1/Notch inhibition as a glucose-lowering treatment for diabetes
por: Kitamoto, Takumi, et al.
Publicado: (2022) -
Reprogramming Cells to Make Insulin
por: McKimpson, Wendy M, et al.
Publicado: (2019)